98%
921
2 minutes
20
Purpose: This study measured associations of peak oxygen uptake (V̇O2peak) with cardiometabolic risk factors and quantified cardiometabolic risk misclassification when scaling V̇O2peak for body size and composition, comparing population-specific and universal V̇O2peak cut-points.
Methods: In a population sample of 332 Finnish children (164 girls, 9-11 years), V̇O2peak was determined using a maximal cycle ergometer test and scaled for body mass (BM) and lean mass (LM) using ratio and allometric methods. A continuous cardiometabolic risk score was calculated from age- and sex-specific z-scores of traditional risk factors, with 'increased risk' defined as ≥1 standard deviation above the mean. Receiver operating characteristics curves assessed the ability of V̇O2peak to classify children at increased risk. Associations between V̇O2peak and cardiometabolic risk factors were measured using linear regression analyses. The type and extent of misclassification were calculated by comparing rank differences between allometric and ratio-scaled V̇O2peak, using directly measured cardiometabolic risk vs. V̇O2peak cut-points. Population-specific cut-points based on previously reported cut-points in this sample were compared with universal cut-points from existing meta-analyses.
Results: Scaling using LM, or allometric methods, attenuated associations between V̇O2peak and cardiometabolic risk factors. V̇O2peak scaled by LM-1, BM-0.49, or LM-1.04 demonstrated poor ability to classify increased cardiometabolic risk, whilst V̇O2peak scaled by BM-1 had the highest classification ability in girls and boys (AUC = 0.875 and 0.690 respectively, p < 0.01). Universal cut-points produced fewer false positive classifications than population-specific cut-points.
Conclusions: V̇O2peak appropriately scaled for body size and composition may have limited ability to distinguish cardiometabolic risk in children, with diminished associations with cardiometabolic risk factors. Screening for cardiometabolic risk in children using V̇O2peak ratio-scaled by BM may reflect body size, rather than fitness.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1249/MSS.0000000000003828 | DOI Listing |
Curr Atheroscler Rep
September 2025
Division of Gastroenterology and Hepatology, Lynda K. and David M. Underwood Center for Digestive Health, Houston Methodist Hospital, Houston, TX, USA.
Purpose Of Review: This review aims to characterize the known cardiovascular (CV) manifestations associated with inflammatory bowel disease (IBD) and the underlying mechanisms driving these associations.
Recent Findings: Gut dysbiosis, a hallmark of patients with IBD, can result in both local and systemic inflammation, thereby potentially increasing the risk of cardiovascular disease (CVD) in the IBD population. Micronutrient deficiencies, anemia, and sarcopenia independently increase the risk of CVD and are frequent comorbidities of patients with IBD.
Sleep
September 2025
Center for Sleep Medicine, Hospices Civils de Lyon, Lyon 1 University, Lyon, F-69000, France.
Current treatments for narcolepsy type 1 (NT1) have little impact on psychiatric, cognitive and metabolic comorbidities. Here, we evaluated the feasibility, safety and efficacy of a prospective Exercise Training (ET) program on sleep-related symptoms and comorbidities in NT1. Sedentary adult with NT1 participated in a 6-week supervised ET program followed by a 18-week self-directed program.
View Article and Find Full Text PDFChronobiol Int
September 2025
Consultant, Wayzek Science, St Paul, Minnesota, USA.
Understanding how sleep affects the risk of incident chronic conditions in midlife may reinforce the importance of a healthy sleep pattern for healthy aging and cardiometabolic health. The objective of the study was to examine associations of sleep duration and quality with incident obesity, diabetes and metabolic syndrome in mid-aged adults. Participants without obesity ( = 381), diabetes ( = 509), or metabolic syndrome ( = 487) from the Biomarker Projects in Midlife in the United States study were examined separately for baseline sleep duration and quality and their associations with incident obesity, diabetes, or metabolic syndrome after an average follow-up of 12 years.
View Article and Find Full Text PDFJ Comp Eff Res
September 2025
British Heart Foundation, University of Glasgow, Glasgow, UK.
Composite endpoints amalgamate multiple clinical outcomes into a single measure, offering efficiency gains in clinical trials through increased event rates and reduced sample sizes, thus accelerating clinical development and regulatory approval. However, employing composite endpoints introduces complexities into health technology assessments (HTAs), particularly in economic modeling, due to the varying clinical significance and cost implications of the components. In this paper, we explore best modeling practice for HTAs that are based on clinical trials that employ composite endpoints.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
September 2025
School of Medicine, College of Medicine, Chung Shan Medical University, Taichung, Taiwan.